Huntington’s Disease Treatment Market

See the detailed report:

https://www.fortunebusinessinsights.com/huntington-s-disease-treatment-market-107140

Huntington’s disease (HD) is a rare genetic disorder that causes the progressive degeneration of nerve cells in the brain, leading to a range of physical, cognitive, and psychiatric symptoms. There is currently no cure for HD, and treatment focuses on managing symptoms and improving quality of life.

The HD treatment market includes a range of therapies aimed at managing symptoms and slowing disease progression. Some of the commonly used treatments include drugs that regulate dopamine levels in the brain, such as tetrabenazine and deutetrabenazine, and drugs that manage psychiatric symptoms, such as antidepressants and antipsychotics.

The global “Huntington’s Disease Treatment Market” size is expected to reach USD 2,932.2 million by 2030, exhibiting a CAGR of 17.5% during the forecast period, states Fortune Business Insights in a report titled “Huntington’s Disease Treatment Market, 2023-2030.” The market size stood at USD 848.0 million in 2022.